Skip to main content

Table 5 Comparison of mean ± SD macronutrient intake at baseline and 12-weeks

From: Does a ketogenic diet have beneficial effects on quality of life, physical activity or biomarkers in patients with breast cancer: a randomized controlled clinical trial

Variable KD
Mean ± SD
Control
Mean ± SD
MD (0.95 CI) p-value
Energy (Kcal/day)
 Before 1743 ± 305 1789 ± 323 −45 (− 222,131) 0/60
 After 1245 ± 360 1600 ± 304 − 355 (− 577,-132) 0/003
p-value 0</001 0/001   
Carbohydrate (gr)
 Before 235 ± 52 238 ± 54 −2.6 (−32,27) 0/85
 After 22 ± 11 208 ± 60 − 185 (− 210,-159 0</001a
p-value 0</001 0/03   
Protein (gr)
 Before 73 ± 13 71 ± 22 1.5 (−8.9,11.9) 0/76
 After 61 ± 61 72 ± 71 −10 (−21.9,1.5) 0.41a
p-value 0/02 0/003   
Fat (gr)
 Before 56 ± 11 61 ± 15 −4.6(−12.2,3) 0/23
 After 101 ± 32 53 ± 11 48 (31,65) 0</001a
p-value 0</001 0/007   
  1. Student t-test was used to compare the continuous variables between the two groups. Paired sample t-test was used to compare the continuous variables within the groups
  2. MD Mean difference
  3. CI Confidence interval
  4. aAncova: Adjusted for baseline value and energy